Asston Pharmaceuticals Ltd
Ticker: APL
Decent
63/100
☆ Add to Watchlist
Investing Reference
Price
91.90
Market Cap
78.23
Debt/Equity
0.6573
ROE %
42.394
PB
7.0923
Promoter %
50.661
Pledge %
0.000
1Y Rev Growth %
57.310
5Y Rev Growth %
NP Margin %
15.072
NP Margin 5Y Avg %
Trading Reference
1M Return %
-11.000
6M Return %
-26.451
1Y Return %
-26.451
% Away 52W High
37.106
% Away 52W Low
0.878
Daily Volume
8000
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Asston Pharmaceuticals Ltd is currently trading near a strong support level, with recent price action showing increased volume on upward movements. If the stock can break through the resistance level at $45, there is a potential upside of 20%. However, if it falls below the support level of $35, there could be a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Acknit Industries Ltd
Acknit Industries Ltd shows potential but is currently facing several challenges that make it a risky investment.
View details
M
Mirae Asset NYSE FANG+ ETF
The Mirae Asset NYSE FANG+ ETF offers exposure to high-growth sectors, but investors should be cautious of valuation and execution risks.
View details
O
Olatech Solutions Ltd
Olatech Solutions Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
S
Share Samadhan Ltd
Share Samadhan Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
O
Oswal Overseas Ltd
Oswal Overseas Ltd presents a mixed outlook with some strengths in business fundamentals but significant risks in growth and market sentiment.
View details
I
Icodex Publishing Solutions Ltd
Icodex Publishing Solutions Ltd presents several risks, particularly in growth and profitability metrics, making it a risky investment at this time.
View details
R
R R Financial Consultants Ltd
R R Financial Consultants Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
O
Orient Press Ltd
Orient Press Ltd shows potential challenges in growth and profitability, with valuation concerns and weak market sentiment.
View details
P
Party Cruisers Ltd
Party Cruisers Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
L
Le Lavoir Ltd
Le Lavoir Ltd shows potential in a future-ready sector, but inconsistent growth and weak market sentiment raise concerns.
View details
N
Nexxus Petro Industries Ltd
Nexxus Petro Industries Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
T
Titan Securities Ltd
Titan Securities Ltd shows decent potential with consistent growth and profitability metrics, but caution is advised due to valuation concerns and execution risks.
View details
B
Bisil Plast Ltd
Bisil Plast Ltd shows potential in a future-ready sector, but inconsistent growth and profitability metrics raise concerns about its investment viability.
View details
O
Onyx Biotec Ltd
Onyx Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics, warranting cautious investment.
View details
P
Pulz Electronics Ltd
Pulz Electronics Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
M
Makers Laboratories Ltd
Makers Laboratories Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Asston Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to enhancing healthcare through innovative and affordable medications. Catering to a diverse range of therapeutic areas, the company focuses on improving the quality of life for patients across the nation. Asston's commitment to research and development ensures the introduction of cutting-edge solutions that meet the evolving healthcare needs. With a strong distribution network and a reputation for quality, Asston Pharmaceuticals is a trusted partner for healthcare providers and patients alike.
- Leading player in the Indian pharmaceutical sector
- Focus on innovative and affordable medications
- Covers diverse therapeutic areas
- Commitment to research and development
- Strong distribution network
- Trusted partner for healthcare providers and patients
Investment Thesis
Asston Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company for robust future performance in the rapidly evolving pharmaceutical sector.
- Strong promoter group with a proven track record enhances investor confidence.
- Digital services segment poised for substantial growth, tapping into increasing healthcare digitization.
- Attractive valuation metrics compared to industry peers, offering a favorable entry point.
- Commitment to innovation and R&D supports long-term sustainability and market leadership.
- Positive market sentiment and robust financials indicate potential for significant returns.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into emerging markets
- Strong R&D pipeline
- Potential for strategic partnerships
- Government support for pharma sector
Risks ⚠️
- Regulatory challenges in drug approvals
- Intense competition in the industry
- Fluctuating raw material costs
- Dependence on key patents
- Market volatility affecting stock price
Peer Perspective
Asston Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, necessitating consistent margin stability and growth acceleration for a potential rerating in the competitive pharma landscape.
Future Outlook
Asston Pharmaceuticals Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence; however, successful execution and stringent cost control will be crucial to achieving long-term value for investors.
AI FAQs for Retail Users
- Q: What does Asston Pharmaceuticals Ltd do?A: Asston Pharmaceuticals Ltd develops and manufactures a range of pharmaceutical products for various health conditions.
- Q: Is Asston Pharmaceuticals Ltd a profitable company?A: Profitability can vary; please check recent financial reports for the latest performance details.
- Q: What are the risks of investing in Asston Pharmaceuticals Ltd?A: Risks include market competition, regulatory changes, and potential fluctuations in revenue.
- Q: How can I buy shares of Asston Pharmaceuticals Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find more information about Asston Pharmaceuticals Ltd?A: Company information is available on their official website and through financial news platforms.
📊 Stock Investment Checklist (100 Points)
Asston Pharmaceuticals Ltd • Updated: 2025-09-17 06:20:22
-
10BusinessHighPharmaceutical sector shows potential for growth, but competition is high.
-
10GrowthHighConsistent revenue growth observed, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are above industry average, indicating potential overvaluation.
-
6BalanceGoodModerate debt levels, but liquidity is a concern.
-
5GovernanceGoodPromoter holding is stable, but some pledging is noted.
-
4DriversGoodGrowth drivers are present, but execution risks are significant.
-
3TechnicalsLowMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 63 / 100
• Decent
Asston Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100